Interventional Cardiology: Market Research Report

June 2010 | 492 pages | ID: I5C4C5B802DEN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Interventional Cardiology in US$ Million.

The market for Interventional Cardiology Devices is analyzed by the following product segments: Coronary Stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings/ Vascular Closure Devices, and Others.

The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for each region for the period 2006 through 2015.

The report profiles 73 companies including many key and niche players such as Abbott Laboratories, Abbott Vascular, AGA Medical Holdings, Inc., B. Braun Melsungen AG, Biosensors International Group Ltd., Boston Scientific Corporation, Cardiac Dimensions, Inc., COOK Medical, Inc., Cordis Corporation, Edwards Lifesciences Corp., Eurocor GmbH, ev3, Inc., Goodman Co., Ltd., Medtronic, Inc., Medtronic Vascular, Inc., Merit Medical Systems, Inc., NMT Medical, Spectranetics Corporation, St. Jude Medical, Inc., Terumo Corporation, Terumo Medical Corporation, Thermocore Medical Limited, Translumina GmbH, Vascular Solutions, Inc., and Volcano Corporation.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Contents

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Coronary Stents
Peripheral Devices
Angioplasty Catheters
Intravascular Ultrasound
Vascular Sealings/ Vascular Closure Devices
Others

II. EXECUTIVE SUMMARY

1.GLOBAL MARKET REVIEW

Table 1. Global Coronary Heart Disease Prevalence by Region (includes corresponding Graph/Chart)

Interventional Cardiology: An Introduction
Coronary Artery Disease – The Leading Cause for Interventional Cardiology Procedures

Table 2. Deaths Due to Major Cardiovascular Diseases in the US: Percentage Share Breakdown by Disease Type (includes corresponding Graph/Chart)

Market Estimates and Forecasts
Geographic Market Performance
Product Segment Review
Market Overview
Interventional Cardiology Technology Prospects
Coronary Stents - The Leading Interventional Cardiology Device Segment

Table 3. World Coronary Stents Market (2006-2011): Percentage Breakdown of Value Sales by Stent Type for Bare-Metal Stents and Drug-eluting Stents (includes corresponding Graph/Chart)

Table 4. World Bare Metal Stents Market (2007-2010): Percentage Breakdown of Value Sales by Geographic Region – US, Japan, Europe, Asia-Pacific and Rest of World (includes corresponding Graph/Chart)

Drug-Eluting Stents – The Best-Selling Coronary Stents

Table 5. World Drug-Eluting Stents Market (2007-2010): Percentage Breakdown of Value Sales by Geographic Region – US, Japan, Europe, Asia-Pacific and Rest of World (includes corresponding Graph/Chart)

Drug-Eluting Stents Market Bounces Back
Cypher And Taxus Dominate Global DES Market
Drug Eluting Stent System – Safety Concerns
Bare Metal Coronary Stents
IVUS Devices – The Fastest Growing Segment
Vascular Sealings – A Fast Growing IC Segment
Future Prospects Of Vascular Sealings
Embolic Protection Devices – Improving PCI Outcomes In SVG Procedures
DES Opportunities For Smaller Players

2.MARKET TRENDS & ISSUES

Aging Population Propels Coronary Stent Market

Table 6. Aging Population in the US by Age Group for Years 1990-2030 (includes corresponding Graph/Chart)

Next Generation Stents – A Boon for Treating Coronary Diseases
Balloon Angioplasty Wins Edge Over Conventional Bypass Surgery
Interventional Cardiology Procedural Volume Recording Steady Growth
Technological Advancements to Drive Growth
Lack of Pharmacological Alternatives Boost Demand for Cardiovascular Catheters
Molding Material and Technology Advancements
Diagnostic Catheters – Advance from the Workhorse 8 Fr.
Smaller Shafts and Colors – The New in Catheters
Coronary Stents Market Challenged by Drug Therapy
PTCA Catheters – Affected by Direct Stenting
Angioplasty – Under Price Pressure
Restenosis – The Unsolved Problem
Cell Transplantation – A Major Threat to Coronary Stents
Repeat Interventional Procedures Affected by the Advent of Drug-Eluting Stents
Energy-Based Solutions Compete with Conventional Interventional Systems
New Pharmacological Therapies Minimizing the Need for Interventional Procedures

3.COMPETITIVE LANDSCAPE

The BIG Four
Major Interventional Cardiology Device Players
Coronary Stents – Leading Players

Table 7. World Coronary Stents Market by Leading Players (2009-2011): Market Share Breakdown for Boston Scientific, Abbott/Guidant, Johnson & Johnson , Medtronic, and Others (includes corresponding Graph/Chart)

Bare Metal Stents – Leading Players

Table 8. World Bare Metal Stents Market (2009-2011): Percentage Breakdown of Revenues by Leading Players – Abbott/Guidant, Medtronic, Boston Scientific, Johnson & Johnson and Others (includes corresponding Graph/Chart)

Drug-Eluting Stents – Leading Players

Table 9. World Drug Eluting Stents Market (2009-2011): Market Share Breakdown by Leading Players - Boston Scientific, Abbott/Guidant, Johnson & Johnson, Medtronic and Others (includes corresponding Graph/Chart)

4.OVERVIEW OF INTERVENTIONAL CARDIOLOGY

Cardiology
Interventional Cardiology
The Ideal Candidate for Interventional Cardiology
Interventional Cardiology Benefits
Interventional Cardiology Risks
Certain Cardiovascular Diseases for Interventional Cardiology
Coronary Artery Disease
Peripheral Arterial Disease
Heart Valve Disease
Interventional Cardiology Procedures
Cardiac Catheterization
Coronary Angioplasty

Table 10. World Angioplasty and Stent Procedures in Millions (2007-2011) (includes corresponding Graph/Chart)

Valvuloplasty
Percutaneous Valve Replacement
Coronary Thrombectomy
Cardiac Ablation
Atherectomy
Interventional Cardiology Devices
Coronary Stents
Bare Metal Stents
Select Leading Bare-Metal Stents by Company
Drug Eluting Stents
Select Leading Drug-Eluting Stents by Company
Drugs for Coating DESs
Select Leading Coronary Stent Brands
Cypher
Structure and Delivery Mechanism
Taxus
Structure and Delivery Mechanism
Catheters
Angiography Catheters
PTCA Catheters
Types of Balloon Catheters
Rapid -Exchange PTCA Balloon Catheter
Over-The-Wire PTCA Balloon Catheter
Peripheral Devices
Intravascular Ultrasound
Vascular Sealings/ Vascular Closure Devices
Embolic Protection Devices
Others
Atherectomy Catheters
Guide Catheters
Guidewires

5.PRODUCT APPROVALS

Conditional IDE Approval for ORBIT II Clinical Trial with Diamondback 360® System
US FTC Approves Getinge and Datascope Merger
Xtent Obtains CE Mark for Custom NX Drug-Eluting Stent System
Invatec Obtains CE Mark for IN.PACT Falcon Paclitaxel-Eluting PTCA Balloon Catheter
Medtronic Obtains Approval for Endeavor in Japan
Atrium Medical Gains EU Approval for Cinatra™
Boston Scientific Obtains FDA Approval for TAXUS® Liberte®
Boston Scientific Obtains FDA Approval for Taxus® Express2™
Health Canada Approves Abbott’s XIENCE V®
Angiotech Receives CE Certification for Zilver® PTX® Stent
NMT Medical Obtains PMA Approval from US FDA for STARFlex® Implant
Cordis Receives FDA Approval for a Smaller Version of CYPHER® Stent
Boston Scientific Receives CE Mark for PROMUS® ElementTM
Biosensors International Obtains CE Mark for Small- Diameter BioMatrix Stent
AGA Medical Receives CE Mark for AMPLATZER® Cardiac Plug
AGA Medical Gains CE Mark Approval for AMPLATZER® Vascular Plug III
AGA Medical Gets CE Mark for AMPLATZER® Duct Occluder II
Cook Medical Receives FDA Clearance for Balloon Dilatation Catheter
Cardiac Dimensions® Receives CE Mark for Carillontm Mitral Contour Systemtm
Medtronic Receives the US FDA Approval to Use Endeavor® Stent
Boston Scientific to Market TAXUS® Liberte® Stent System in Canada
Global Therapeutics Receives CE Mark for Global Therapeutics GTX Coronary Stent System
OrbusNeich Obtains CE Mark
Abbott’s 2.25mm-Sized XIENCE™ V Drug Eluting Stent receives CE Mark of Approval
Cook Medical Gains CE Mark Approval for MiraFlexTM High Flow Microcatheter
Terumo Receives CE Certification for NoboriTM DEC Stent System
Abbott Applies for Approval of XIENCE™ V in Japan
Tryton Medical’s Side-Branch Stent Achieves CE Mark Approval
MIV Therapeutics Obtains DCGI Approval
Cook Medical’s Zilver Stent Receives Approval for Vascular Use In Canada

6.PRODUCT LAUNCHES

Boston Scientific Introduces iCross Coronary Imaging Catheter
Boston Scientific Launches TAXUS® Liberte® DES System in Japan
Abbott Introduces VOYAGER™ NC Coronary Balloon Catheter
Invatec Introduces Coronary Drug-Eluting Balloon Platform IN.PACT
Terumo Launches Glidewire AdvantageTM Peripheral Guidewire
Invatec Launches REEF HPTM PTA Balloon Catheter
Tryton Medical Launches Side-Branch Stent
Terumo Interventional Systems Introduces Coronary Diagnostic Catheters
Medtronic Launches Endeavor Sprint Drug Eluting Stent
Medtronic to Introduce Balloon Catheters and Coronary Stents
Cordis Introduces SAVVY® and SLEEK™ Balloon Catheters
Volcano Launches Integrated FFR and Rotational IVUS
Medtronic Launches Defender Embolic Protection Filter
Biosensors Introduces BioMatrix® Drug-Eluting Stent
St. Jude Medical Unveils Refllexion Spiral XTM Catheter
Volcano Launches PrimeWire™ Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles

7.RECENT INDUSTRY ACTIVITY

Medtronic to Acquire Invatec
Lake Region Medical Acquires Brivant Medical
Abbott Acquires Evalve
Texcel and Circle Medical Announce Merger
Volcano and Lumen Biomedical Enter into Distribution Agreement
Volcano Enters into Alliance with Siemens Healthcare
Spectranetics Acquires Embolic Protection Products from Kensey Nash
MEDRAD Merges With Possis Medical
St. Jude Medical to Acquire RadiMedical
St. Jude Medical Acquires EP MedSystems
Volcano Takes Over Novelis
Heraeus Vadnais Takes Over Synovis Life Technologies
Novation Signs Deal with Medtronic for Endeavor Zotarolimus DES
Boston Scientific Enter into Agreement with Trivitron
Volcano and Royal Philips Electronics Sign North America Resale Agreement
MMDIA Receives Patent Allowance for BetaWire™ Guidewire
Cordis to Market ClearStream Technologies’ Catheters
Abbott Laboratories Acquires Nova Science

8.FOCUS ON SELECT PLAYERS

Abbott Laboratories (US)
Abbott Vascular (US)
AGA Medical Holdings, Inc. (US)
B. Braun Melsungen AG (Germany)
Biosensors International Group Ltd. (Singapore)
Boston Scientific Corp. (US)
Cardiac Dimensions, Inc. (US)
COOKMedical, Inc. (US)
Cordis Corp. (US)
Edwards Lifesciences Corp. (US)
Eurocor GmbH (Germany)
ev3, Inc. (US)
Goodman Co., Ltd. (Japan)
Medtronic, Inc. (US)
Medtronic Vascular, Inc. (US)
Merit Medical Systems, Inc. (US)
NMT Medical (US)
Spectranetics Corp. (US)
St. Jude Medical, Inc. (US)
Terumo Corp. (Japan)
Terumo Medical Corporation (Japan)
Thermocore Medical Limited (UK)
Translumina GmbH (Germany)
Vascular Solutions, Inc. (US)
Volcano Corp. (US)

9.GLOBAL MARKET PERSPECTIVE

Table 11. World Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region – US, Japan, Europe, Asia-Pacific (Excl. Japan) and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 12. World 10-Year Perspective for Interventional Cardiology Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Japan, Europe, Asia-Pacific (Excl. Japan) and Rest of World Markets for Years 2006, 2009 and 2015 (includes corresponding Graph/Chart)

Table 13. World Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Product Segment –Coronary Stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 14. World 10-Year Perspective for Interventional Cardiology Devices by Product Segment – Percentage Breakdown of Dollar Sales for Coronary Stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings and Others Markets for Years 2006, 2009 and 2015 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

A. MARKET ANALYSIS

Coronary Artery Disease

Table 15. The Ten Leading Causes of Death in the US (includes corresponding Graph/Chart)

Coronary Heart Disease Statistics
Rising Obesity Levels Increase Number of Interventional Cardiology Procedures
Current and Future Analysis
Market Overview
Coronary Stents Market

Table 16. Angioplasty and Stent Procedures Performed in the US: 2006-2011 (In Thousands) (includes corresponding Graph/Chart)

Table 17. US Coronary Stents Market (2006-2011): Number of Stents Used in Angioplasty Procedures by Stent Type (in Thousands) (includes corresponding Graph/Chart)

The Emergence, Rise, Fall and Re-emergence of Drug Eluting Stents
The Angioplasty and Stents Debate Continues
The Role of Pharmacists
The Huge Potential

Table 18. US Drug Eluting Stents Market (2009): Market Share Breakdown of Value Sales by Leading Brands – Cypher, Endeavor, Taxus, Promus and Xience (includes corresponding Graph/Chart)

Product Approvals
Product Launches
Strategic Corporate Developments
Select Players

B. MARKET ANALYTICS

Table 19. US Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

2.JAPAN

A. MARKET ANALYSIS

Current and Future Analysis
Market Overview
Coronary Stents – The Leading IC Device Segment
US Companies Lead Japanese IC Device Market

Table 20. Japanese Coronary Stents Market (2007): Market Share Breakdown of Value Sales by Major Players - Johnson & Johnson, Boston Scientific, Abbott/Guidant, Medtronic and Others (in US$ Million) (includes corresponding Graph/Chart)

Table 21. Japanese Bare-Metal Stents Market (2007): Market Share Breakdown of Value Sales by Major Players - Medtronic, Abbott/Guidant, Johnson & Johnson, Boston Scientific,and Others (includes corresponding Graph/Chart)

Drug-Eluting Stents

Table 22. Japanese Coronary Drug-Eluting Stents Market (2009): Market Share Breakdown of Value Sales by Major Player Johnson & Johnson, Boston Scientific and Medtronic

Product Approvals
Product Launches
Select Players

B. MARKET ANALYTICS

Table 23. Japanese Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

3.EUROPE

A. MARKET ANALYSIS

Current and Future Analysis
Market Overview
The DES Market

Table 24. European Coronary Stent Market (2007): Market Share Breakdown of Value Sales by Company - Boston Scientific, Johnson & Johnson, Medtronic, Abbott and Others (includes corresponding Graph/Chart)

Table 25. European Coronary Drug-Eluting Stent Market (2007): Market Share Breakdown of Value Sales by Company - Boston Scientific, Johnson & Johnson, Medtronic, Abbott and Others (includes corresponding Graph/Chart)

Table 26. European Coronary Bare-Metal Stent Market (2007): Market Share Breakdown of Value Sales by Company - Abbott, Medtronic, Boston Scientific, Johnson & Johnson, and Others (includes corresponding Graph/Chart)

Technology Innovation Drives PCI Devices Market in Western Europe

Table 27. Western Europe PCI (Percutaneous Coronary Intervention) Market (2008): Percentage Breakdown of Sales in Value Terms for Boston Scientific, Cordis, Medtronic, Abbott and Others (includes corresponding Graph/Chart)

Table 28. Western Europe Coronary Stent Market (2008) by Stent Type: Percentage Breakdown of Sales in Value Terms for Drug-Eluting Stents and Bare Metal Stents

Table 29. Western Europe Coronary Stent Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Boston Scientific, Cordis, Medtronic, Abbott and Others (includes corresponding Graph/Chart)

Table 30. Western Europe Angioplasty Balloon Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Biotronik, ClearStream, Invatec and Others (includes corresponding Graph/Chart)

Table 31. Western Europe Coronary Catheters Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Cordis, Boston Scientific, Medtronic, Abbott, St. Jude Medical and Others (includes corresponding Graph/Chart)

Table 32. Western Europe Coronary Guidewires Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Cordis, Boston Scientific, Abbott, Medtronic, St. Jude Medical and Others (includes corresponding Graph/Chart)

Table 33. Western Europe Balloon Inflators Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Medtronic, Abbott, Merit Medical, B. Braun and Others (includes corresponding Graph/Chart)

Table 34. Western Europe Embolic Protection Devices Market (2008) by Company: Percentage Breakdown of Sales in Value Terms for Boston Scientific, Medtronic, Abbott, St. Jude Medical and Others (includes corresponding Graph/Chart)

Product Approvals
Product Launches
Strategic Corporate Developments
Select Players

B. MARKET ANALYTICS

Table 35. European Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

4.ASIA-PACIFIC

A. MARKET ANALYSIS

Current and Future Analysis
Market Overview

Table 36. Asia-Pacific Drug Eluting Stents Market (2007): Percentage Breakdown of Value Sales for China, Korea, India, Australia and Others (includes corresponding Graph/Chart)

Table 37. Asia-Pacific Drug Eluting Stents Market (2007): Market Share Breakdown by Leading Players – Microport, Cordis, JW Medical ,Boston Scientific and Others (includes corresponding Graph/Chart)

B. MARKET ANALYTICS

Table 38. Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region – China, India, Korea, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 39. Asia-Pacific 10-Year Perspective for Interventional Cardiology Devices by Geographic Region – Percentage Breakdown of Dollar Sales for China, India, Korea, and Rest of Asia-Pacific Markets for Years 2006, 2009, and 2015 (includes corresponding Graph/Chart)

4A.CHINA

A. MARKET ANALYSIS

Current and Future Analysis
Market Overview
Growth Drivers and Restrains
Healthcare Reforms to Drive Drug-Eluting Stents Growth

B. MARKET ANALYTICS

Table 40. Chinese Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

4B.INDIA

A. MARKET ANALYSIS

Current and Future Analysis
Market Overview
Imported Stents Hold Great Prospects
Availability of Enhanced DES Ensures Quality Care for Heart Patients
Product Approval
Strategic Corporate Developments

B. MARKET ANALYTICS

Table 41. Indian Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

4C.KOREA

A. MARKET ANALYSIS

Current and Future Analysis
Market Outlook
Market Overview
US Companies Dominate Supply Landscape
Korean Imports of Interventional Cardiology Devices: Breakdown by Select Countries of Origin

Table 42. Korean Interventional Coronary Artery Devices Market (2007-2009): Number of Procedures for Diagnostic Angiography, and PTCA Procedures (In Thousands) (includes corresponding Graph/Chart)

B. MARKET ANALYTICS

Table 43. Korean Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Product Segment – Drug Eluting Stents, Intravascular Ultrasound, Guiding Catheters, Balloon Catheters, PTCA Guidewires, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 44. Korean 10-Year Perspective for Interventional Cardiology Devices by Product Segment – Percentage Breakdown of Dollar Sales for Drug Eluting Stents, Intravascular Ultrasound, Guiding Catheters, Balloon Catheters, PTCA Guidewires, and Others Markets for Years 2006, 2009, and 2015 (includes corresponding Graph/Chart)

4D.REST OF ASIA-PACIFIC

A. MARKET ANALYSIS

Current and Future Analysis
Product Approval
Select Player

B. MARKET ANALYTICS

Table 45. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

5.REST OF WORLD

A. MARKET ANALYSIS

Current and Future Analysis
Product Approvals
Product Launch

B. MARKET ANALYTICS

Table 46. Rest of World Recent Past, Current & Future Analysis for Interventional Cardiology Devices Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 73 (including Divisions/Subsidiaries - 82)
Region/CountryPlayers
The United States
Canada
Japan
Europe
Germany
The United Kingdom
Italy
Rest of Europe
Asia-Pacific (Excluding Japan)
Africa